Company intelligence / Profile preview
Xgene Pharmaceutical Inc.
George Town, N/A, Cayman Islandsxgenepharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Xgene has reported positive topline results from late-phase trials of its lead candidate (XG005) for post-surgical and osteoarthritis knee pain. Another program (XG2002), a novel TRPM8 blocker licensed from RaQualia Pharma, is in Phase 1 clinical trials in Australia. The company focuses on non-opioid multimodal analgesics with improved efficacy and safety profiles compared to standard therapies[5][6].
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesMultimodal conjugated molecules (dual-targeting prodrugs)Non-opioid analgesicsTRPM8 channel blockers[3][6][8]
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
RaQualia Pharma Inc.: Licensing agreement for the novel TRPM8 blocker compound RQ‑00434739/XG2002.[7][8]Zhongtai Investment and other venture capital investors participated in funding rounds.[5]
Beyond the preview
Go deeper on Xgene Pharmaceutical Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xgene Pharmaceutical Inc..